Evidence map›Paper›PMID 30691511›Full record

ArticleAddiction science & clinical practice2019

Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention.

Alexis Cooke, Haneefa Saleem, Saria Hassan, Dorothy Mushi, Jessie Mbwambo, Barrot Lambdin

Open access · goldAbstract read
In one paragraph

Article in Addiction science & clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Alexis CookeDepartment of Psychiatry, University of California, San Francisco, 3333 California Street, Suite 485, San Francisco, CA, 94118, USA. alexis.cooke@ucsf.edu.ORCID 0000-0002-7053-1208
Haneefa SaleemJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Saria HassanYale School of Medicine, New Haven, CT, USA.
Dorothy MushiDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania.
Jessie MbwamboDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania.
Barrot LambdinRTI International, San Francisco, CA, USA.
Muhimbili University of Health and Allied Sciences · TZJohns Hopkins University · USRTI International · USUniversity of California, San Francisco · USYale University · US

Funding

Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HIRAM BELTRAN-SANCHEZ · 2016 to 2026
$6.9M
CALIFORNIA CENTER FOR POPULATION TRAINING PROGRAMT32HD007545 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HIRAM BELTRAN-SANCHEZ, Megan M Sweeney · 2001 to 2026
$4.1M
Yale Scholars in Implementation Science (YSIS)K12HL138037 · NHLBI · YALE UNIVERSITY · PI SHARIFI, MAHNOOSH · 2017 to 2021
$3.0M
Reducing Failure-to-Initiate ART among People Who Inject Drugs: the IMAT StrategyR34DA037787 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI LAMBDIN, BARROT HOPKINS · 2014 to 2016
$585k
NHLBI NIH HHS K12 HL138037NICHD NIH HHS P2C HD041022NICHD NIH HHS T32 HD007545NIDA NIH HHS R34 DA037787NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

backgroundIn Dar es Salaam Tanzania, the first opioid treatment program (OTP) in Sub-Saharan Africa, had very high rates of enrollment of people who use drugs (PWUD) but low rates of antiretroviral therapy (ART) initiation among HIV-positive patients. The integrated methadone and anti-retroviral therapy (IMAT) intervention was developed to integrate HIV services into the OTP clinic. The objective of this paper is to better understand the contextual factors that influence the effectiveness of IMAT implementation using the consolidated framework for implementation research (CFIR).

methodsSemi-structured, in-depth interviews were conducted with 35 HIV-positive OTP patients and 8 OTP providers at the Muhimbili National Hospital OTP clinic 6-months after IMAT implementation. Providers were asked about their reactions to and opinions of the IMAT intervention including its implementation, their role in patient education, intervention procedures, and ART dispensing. Interviews with patients focused on their experiences with the IMAT intervention and adapting to the new protocol. Analysis of interview data was guided by the CFIR.

resultsThe CFIR constructs found to be driving forces behind facilitating or impeding IMAT implementation were: intervention characteristics (e.g. complexity, adaptability and evidence related to IMAT), outer setting (e.g. patient needs and resources), and inner setting (e.g. compatibility of IMAT and available resources for IMAT). The most significant barrier to implementation identified in interviews was availability of resources, including workforce limitations and lack of space given patient load. OTP providers and patients felt the design of the IMAT intervention allowed for adaptability to meet the needs of providers and patients.

conclusionsUnderstanding the contextual factors that influence implementation is critical to the success of interventions that seek to integrate HIV services into existing programs for key populations such as PWUD. Approximately 4 months after IMAT implementation, the OTP clinic adopted a 'test-and-treat' model for HIV-positive PWUD, which significantly impacted clinic workload as well as the care context. In this study we highlight the importance of intervention characteristics and resources, as key facilitators and barriers to implementation, that should be actively integrated into intervention protocols to increase implementation success. Similar interventions in other low-resource settings should address the ways intervention characteristics and contextual factors, such as adaptability, complexity and available resources impact implementation in specific care contexts.

Indexed as

Attitude of Health PersonnelAdultAnti-Retroviral AgentsFemaleHealth Care RationingHealth Services AccessibilityHIV InfectionsHumansInterviews as TopicMaleMethadoneMiddle AgedOpiate Substitution TreatmentPatientsPrimary Health CareTanzaniaAnti-Retroviral AgentsMethadoneCare integrationHIVImplementationSubstance use

Identifiers

PMID30691511
PMCPMC6350287
OpenAlexW2936800067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.